Lv1
50 积分 2023-11-01 加入
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features
1天前
已完结
TIGIT-expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D
1个月前
已完结
TIGIT-expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D
2个月前
已完结
Co-blocking TIGIT and PVRIG using a novel bispecific antibody enhances anti-tumor immunity
2个月前
已关闭
Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments
2个月前
已完结
Natural killer cells for antiviral therapy
3个月前
已完结
Nutrient-driven histone code determines exhausted CD8 + T cell fates
3个月前
已完结
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid
4个月前
已完结
Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
4个月前
已完结
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
4个月前
已完结
皖公网安备34019202002308
